Taken together, we propose that miR-224/-520c dependent TUSC3 downregulation enhances the metastatic potentials of NSCLC by imbalance of the activation of the UPR and enhancing HRD1-dependent p53 protein suppression. This evidence concerns the gene TP53 and non-small cell lung carcinoma.